by global advocacy groups to produce and donate more doses to the world instead of focusing on boosters in rich countries.
Bourla told Yahoo Finance that within two days of receiving such a request, Pfizer has been able to work with the country to allow sharing of doses. "The proposed waiver for COVID-19 vaccines, threatens to disrupt the flow of raw materials. It will unleash a scramble for the critical inputs we require in order to make a safe and effective vaccine. Entities with little or no experience in manufacturing vaccines are likely to chase the very raw materials we require to scale our production, putting the safety and security of all at risk," Bourla said.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: